Perspective Therapeutics, Inc. (CATX)
USD 2.97
(-3.26%)
USD 2.97
(-3.26%)
| Breakdown | 2022 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 7.1 Million | 10.79 Million | 10.05 Million | 9.68 Million | 7.31 Million | 5.92 Million |
| Cost of Revenue | 5.47 Million | 6.17 Million | 4.93 Million | 4.55 Million | 4.26 Million | 4.08 Million |
| Gross Profit | 1.63 Million | 4.61 Million | 5.12 Million | 5.12 Million | 3.04 Million | 1.84 Million |
| Operating Expenses | 17.42 Million | 12 Million | 8.55 Million | 8.6 Million | 8.32 Million | 8.57 Million |
| Selling, General and Administrative Expenses | 14.21 Million | 9.42 Million | 7.13 Million | 7.54 Million | 6.85 Million | 6.82 Million |
| Research and Development Expenses | 2.6 Million | 2.58 Million | 1.42 Million | 1.12 Million | 1.47 Million | 1.74 Million |
| Other Expenses | - | - | - | -73 Thousand | 2000.00 | - |
| Cost and Expenses | 22.89 Million | 18.18 Million | 13.49 Million | 13.15 Million | 12.59 Million | 12.65 Million |
| Operating Income | -15.18 Million | -7.39 Million | -3.43 Million | -3.47 Million | -5.27 Million | -6.72 Million |
| Interest Expense | - | 119 Thousand | - | - | - | - |
| Income Tax Expense | - | -119 Thousand | -199 Thousand | -177 Thousand | -294 Thousand | -29 Thousand |
| Earnings before Tax | -14.67 Million | -7.27 Million | -3.38 Million | -3.44 Million | -5.14 Million | -6.7 Million |
| Net Income | -14.67 Million | -7.15 Million | -3.18 Million | -3.26 Million | -4.85 Million | -6.7 Million |
| Earnings Per Share Basic | -0.10 | -0.05 | -0.03 | -0.05 | -0.07 | -0.12 |
| Earnings Per Share Diluted | -0.10 | -0.05 | -0.03 | -0.05 | -0.07 | -0.12 |
| Weighted Average Shares Outstanding | 142.1 Million | 141.98 Million | 103.84 Million | 67.6 Million | 67.04 Million | 55.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 142.1 Million | 141.98 Million | 103.84 Million | 67.6 Million | 67.04 Million | 55.15 Million |
| Gross Margin | 0.23 | 0.43 | 0.51 | 0.53 | 0.42 | 0.31 |
| EBIT Margin | -2.09 | -0.68 | -0.34 | -0.36 | -0.72 | -1.13 |
| Profit Margin | -2.07 | -0.66 | -0.32 | -0.34 | -0.66 | -1.13 |
| EBITDA | -14.83 Million | -7.39 Million | -3.42 Million | -3.47 Million | -5.3 Million | -6.7 Million |
| Earnings Before Tax Margin | -2.14 | -0.68 | -0.34 | -0.36 | -0.72 | -1.14 |
| Breakdown | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 FY | 2022 Q2 | 2022 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.9 Million | 1.5 Million | 1.83 Million | 7.1 Million | 1.83 Million | 1.71 Million |
| Cost of Revenue | 1.44 Million | 1.84 Million | 1.57 Million | 5.47 Million | 1.43 Million | 1.3 Million |
| Gross Profit | 462 Thousand | -340 Thousand | 254 Thousand | 1.63 Million | 403 Thousand | 414 Thousand |
| Operating Expenses | 10.99 Million | 11.03 Million | 11.45 Million | 17.42 Million | 3.6 Million | 4.62 Million |
| Selling, General and Administrative Expenses | 5.55 Million | 5.98 Million | 7.83 Million | - | 2.99 Million | 3.91 Million |
| Research and Development Expenses | 5.72 Million | 5.65 Million | 3.85 Million | - | 613 Thousand | 708 Thousand |
| Other Expenses | - | 2000.00 | -233 Thousand | - | - | - |
| Cost and Expenses | 12.44 Million | 12.87 Million | 13.03 Million | 22.89 Million | 5.03 Million | 5.92 Million |
| Operating Income | -10.53 Million | -11.37 Million | -11.2 Million | -15.18 Million | -3.2 Million | -4.2 Million |
| Interest Expense | 14 Thousand | 28 Thousand | 18 Thousand | - | 400 Thousand | 140 Thousand |
| Income Tax Expense | 278 Thousand | -215 Thousand | -10.5 Million | - | -702 Thousand | -140 Thousand |
| Earnings before Tax | -10.08 Million | -11.1 Million | -10.87 Million | -14.67 Million | -2.9 Million | -4.06 Million |
| Net Income | -10.35 Million | -11.1 Million | -371 Thousand | -14.67 Million | -2.19 Million | -3.92 Million |
| Earnings Per Share Basic | -0.04 | -0.04 | -0.00 | - | -0.02 | -0.03 |
| Earnings Per Share Diluted | -0.04 | -0.04 | -0.00 | - | -0.02 | -0.03 |
| Weighted Average Shares Outstanding | 280.55 Million | 279.98 Million | 228.59 Million | 142.1 Million | 142.11 Million | 142.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 280.55 Million | 279.98 Million | 228.59 Million | 142.1 Million | 142.11 Million | 142.07 Million |
| Gross Margin | 0.24 | -0.23 | 0.14 | 0.23 | 0.22 | 0.24 |
| EBIT Margin | -5.14 | -7.39 | -5.82 | - | -1.69 | -2.45 |
| Profit Margin | -5.42 | -7.40 | -0.20 | -2.07 | -1.20 | -2.29 |
| EBITDA | -9.8 Million | -11.07 Million | -10.65 Million | - | -3.1 Million | -4.2 Million |
| Earnings Before Tax Margin | -5.52 | -7.58 | -6.12 | -2.14 | -1.75 | -2.45 |
ONGC
KGPETRO
ELG
DDEJF
PRAJIND
3816